These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25076754)

  • 1. [Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in the acute phase of alloxan-induced diabetes in rats].
    Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Faĭzullin RM; Malkin MP; Priakhina KE; Kalugina AV
    Eksp Klin Farmakol; 2014; 77(4):14-20. PubMed ID: 25076754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].
    Volchegorskii LA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Pryakhina KE; Kalugina AV
    Ross Fiziol Zh Im I M Sechenova; 2015 Mar; 101(3):258-67. PubMed ID: 26016320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anxiolytic and antidepressant effects of emoxipine, reamberin and mexidol in experimental diabetes mellitus].
    Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Pryakhina KE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):52-57. PubMed ID: 28638031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin potentiating and antidepressant effects of 3-oxypyridine and succinic acid derivatives].
    Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Faĭzullin RM
    Eksp Klin Farmakol; 2014; 77(5):6-9. PubMed ID: 25033564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective effect of 3-oxypyridine and succinic acid derivatives under conditions of acute alloxan-induced intoxication in mice].
    Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Malkin MP; Maĭzyllin RM; Priakhina KE; Kalugina AV
    Eksp Klin Farmakol; 2014; 77(1):13-6. PubMed ID: 24649596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].
    Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu
    Eksp Klin Farmakol; 2011; 74(5):17-25. PubMed ID: 21809693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
    Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu
    Eksp Klin Farmakol; 2011; 74(12):27-32. PubMed ID: 22379879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antidepressant effect of 3-oxypyridine and succinic acid derivatives (experimental study)].
    Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Malkin MP; Faizullin RM; Pryakhina KE; Kalugina AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):48-52. PubMed ID: 26081324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in experimental diabetes mellitus].
    Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):50-61. PubMed ID: 23887452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes.
    Volchegorskii IA; Rassokhina LM; Miroshnichenko IY
    Bull Exp Biol Med; 2013 May; 155(1):56-64. PubMed ID: 23667872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the anxiolytic effects of 3-hydroxypyridine and succinic acid derivatives.
    Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Malkin MP; Pryakhina KE; Kalugina AV
    Bull Exp Biol Med; 2015 Apr; 158(6):756-61. PubMed ID: 25894772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ANTIANHEDONIC EFFECT OF 3-OXYPYRIDINE AND SUCCINIC ACID DERIVATIVES].
    Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Pryakhina KE
    Ross Fiziol Zh Im I M Sechenova; 2016 Nov; 102(11):1312-22. PubMed ID: 30193447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of 3-oxypiridine and succinic acid derivates antidepressant activity in mice].
    Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Faĭzullin RM
    Eksp Klin Farmakol; 2013; 76(7):6-10. PubMed ID: 24006608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antidepressant action of emoxipin and mexidol in mice with alloxan diabetes].
    Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu
    Eksp Klin Farmakol; 2009; 72(2):11-5. PubMed ID: 19441720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of Hypericum perforatum on depression and anxiety in a type 2 diabetic rat model.
    Husain GM; Chatterjee SS; Singh PN; Kumar V
    Acta Pol Pharm; 2011; 68(6):913-8. PubMed ID: 22125957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of 3-oxypyridine and succinic acid derivatives on obsessive-compulsive activity of mice in marble-burying test].
    Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Faĭzullin RM; Priakhina KE
    Eksp Klin Farmakol; 2014; 77(10):10-4. PubMed ID: 25518521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An effect of 3-oxypyridine and succinic acid derivatives on the time of reduction of anxiety and depression symptoms in alcohol withdrawal treatment].
    Volchegorskii IA; Izarovskii BV; Shamaeva TN; Izarovskaia IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):63-71. PubMed ID: 34693691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia].
    Volchegorskiĭ IA; Miroshnichenko II; Rassokhina LM; Faĭzullin RM; Priakhina KE; Malkin MP; Kalugina AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):123-127. PubMed ID: 25726791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.